1. The added value of metabolic imaging with FDG-PET in oesophageal cancer: prognostic role and prediction of response to treatment

   • Emilio Bombardieri

   Editorial commentary 30 May 2006 Pages: 753 - 758

2. Significant clinical impact and prognostic stratification provided by FDG-PET in the staging of oesophageal cancer

   • Cuong P. Duong
   • Helen Demitriou
   • Rodney J. Hicks

   Original Article 10 February 2006 Pages: 759 - 769

   

3. FDG-PET status following chemoradiotherapy provides high management impact and powerful prognostic stratification in oesophageal cancer

   • Cuong P. Duong
   • Rodney J. Hicks
   • Robert J. S. Thomas

   Original article 21 March 2006 Pages: 770 - 778

   

4. The role of FDG-PET/CT in the detection of recurrent colorectal cancer

   • Jana Votrubova
   • Otakar Belohlavek
   • Vladimira Stahalova

   Original article 25 March 2006 Pages: 779 - 784

   

5. Brown fat in breast cancer patients: analysis of serial ¹⁸F-FDG PET/CT scans

   • C. Rousseau
   • E. Bourbouloux
   • M. Campone

   Original article 05 April 2006 Pages: 785 - 791

   

6. Serial O-(2-[¹⁸F]fluoroethyl)-L-tyrosine PET for monitoring the effects of intracavitary radioimmunotherapy in patients with malignant glioma

   • Gabriele Pöpperl
   • Claudia Götz
   • Klaus Tatsch

   Original article Open access 21 March 2006 Pages: 792 - 800

   

7. Comparison of the diagnostic performance of FDG-PET and VBM-MRI in very mild Alzheimer’s disease

   • Takashi Kawachi
   • Kazunari Ishii
   • Etsuro Mori

   Original article 21 March 2006 Pages: 801 - 809

   

8. Peripheral benzodiazepine receptors in the brain of cirrhosis patients with manifest hepatic encephalopathy

   • Peter Iversen
   • Dorthe Aagaard Hansen
   • Susanne Keiding

   Original article 21 March 2006 Pages: 810 - 816

   

9. Loss of neuronal integrity: a cause of hypometabolism in patients with traumatic brain injury without MRI abnormality in the chronic stage

   • Tohru Shiga
   • Katsunori Ikoma
   • Nagara Tamaki

   Original article 25 March 2006 Pages: 817 - 822

   

10. Quantitative assessment of SSTR2 expression in patients with non-small cell lung cancer using⁶⁸Ga-DOTATOC PET and comparison with¹⁸F-FDG PET

    • Antonia Dimitrakopoulou-Strauss
    • Vassilios Georgoulias
    • Ludwig G. Strauss

    Original article 29 March 2006 Pages: 823 - 830

    

11. [^99mTc]Demotate 2 in the detection of sst₂-positive tumours: a preclinical comparison with [¹¹¹In]DOTA-tate

    • Theodosia Maina
    • Berthold A. Nock
    • Marion de Jong

    Original article 28 March 2006 Pages: 831 - 840

    

12. In vivo tumor angiogenesis imaging with site-specific labeled ^99mTc-HYNIC-VEGF

    • Francis G. Blankenberg
    • Marina V. Backer
    • Joseph M. Backer

    Molecular imaging 13 May 2006 Pages: 841 - 848

    

13. Pivotal role of nanotechnologies and biotechnologies for molecular imaging and therapy

    • Giovanni Lucignani

    Focus on.. 07 June 2006 Pages: 849 - 851

14. Submillimetre spatial resolution is feasible in positron emission tomography

    • Klaus P. Schäfers
    • O. Schober
    • M. Schäfers

    Letter to the editor 16 May 2006 Pages: 852 - 853

    

15. Bilateral adrenal metastases from malignant melanoma: concordant findings on ¹⁸F-FDG and ¹⁸F-FDOPA PET

    • Nagabhushan Seshadri
    • Josephine Wat
    • Kottekkattu Balan

    Image of the month 13 May 2006 Pages: 854 - 855

16. Persistent aseptic meningitis due to post-surgical spinal CSF leakage: value of fused ^111mIn-DTPA SPECT-CT cisternography

    • Riemer H. J. A. Slart
    • Klaas-Pieter Koopmans
    • Bauke M. de Jong

    Image of the month 13 May 2006 Pages: 856 - 856